Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
909.4 USD | +1.03% | +1.54% | +3.37% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.37% | 96.73B | |
-0.35% | 103B | |
+1.28% | 21.31B | |
-16.50% | 21.21B | |
-6.54% | 18.79B | |
-42.14% | 16.37B | |
-24.30% | 13.68B | |
+7.98% | 13.44B | |
+21.88% | 10.98B | |
-21.60% | 8.56B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Morgan Stanley Raises Regeneron Pharmaceuticals' Price Target to $625 From $619, Maintains Equalweight Rating